Displaying 1 - 12 of 14
Liver Tumours
4

Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024

View
Liver Tumours
4

Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024

View
Liver Tumours
4

Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024

View
Liver Tumours
4

Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Liver Tumours
5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021

View
Displaying 1 - 12 of 14